🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Thioplex®

Found 28 matching trials

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

PHASE2

The purpose of this study is to find out if removing a specific type of whi...

Status

Terminated

Location

Memorial SloanKettering Cancer Center

Start Date

2018-07-23

Trial ID

NCT03615144

Treatments Being Tested

Melphalan Thiotepa Clofarabine Fludarabine Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®)CliniMACS reagents

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

PHASE1

This is a research study involving the treatment of patients with hematolog...

Status

Terminated

Location

Thomas Jefferson University

Start Date

2011-04

Trial ID

NCT01350258

Treatments Being Tested

Fludarabine Thiotepa Total Body Irradiation (TBI)Donor Lymphocyte Infusion (DLI)Melphalan Hematopoietic stem cell transplantation (HSCT)

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

PHASE3

Allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) is a recog...

Status

Completed

Location

CHU Amiens

Start Date

2016-02-23

Trial ID

NCT02623309

Treatments Being Tested

Allogeneic (Allo) hematopoietic stem cell transplantation

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

PHASE2

The purpose of this study is to determine whether a repeat dose administrat...

Status

Completed

Location

Algemeen Ziekenhuis Sint-Jan

Start Date

2015-10-09

Trial ID

NCT02500550

Treatments Being Tested

ATIR101 Haploidentical hematopoietic stem cell transplantation (HSCT)TBI regime Non-TBI regime

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

PHASE2

The participants are being asked to take part in this clinical trial becaus...

Status

Terminated

Location

St. Jude Children's Research Hospital

Start Date

2023-03-14

Trial ID

NCT05579769

Treatments Being Tested

Ruxolitinib Mesna Anti-thymocyte globulin (ATG)Cyclosporine Cyclophosphamide Fludarabine Methotrexate Total Body Irradiation (radiation treatment)Bone marrow infusion Busulfan Thiotepa

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

PHASE1

Patients with refractory hematologic malignancies, including those who deve...

Status

Completed

Location

St. Jude Children's Research Hospital

Start Date

2010-05

Trial ID

NCT01068301

Treatments Being Tested

Plerixafor

Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy

PHASE2

In this study, participants with high-risk hematologic malignancies undergo...

Status

Completed

Location

St. Jude Children's Research Hospital

Start Date

2013-05-16

Trial ID

NCT01807611

Treatments Being Tested

Total Lymphoid Irradiation Fludarabine Cyclophosphamide Thiotepa Melphalan HPC,A Infusion TC-NK Infusion G-CSF Mesna CliniMACS Mycophenolate mofetil

MT2004-30: Tomotherapy for Solid Tumors

PHASE1

RATIONALE: A peripheral blood stem cell transplant or bone marrow transplan...

Status

Terminated

Location

Masonic Cancer Center at University of Minnesota

Start Date

2005-08

Trial ID

NCT00623077

Treatments Being Tested

filgrastim busulfan etoposide ifosfamide melphalan thiotepa stem cell transplantation tomotherapy total marrow irradiation Mesna Whole lung radiation

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

PHASE1

The purpose of this study is to determine whether a lung transplantation pr...

Status

Recruiting

Location

UPMC Presbyterian

Start Date

2018-04-19

Trial ID

NCT03500731

Treatments Being Tested

CD3/CD19 negative hematopoietic stem cells Rituximab Alemtuzumab Fludarabine Thiotepa G-CSF Hydroxyurea

Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

PHASE2

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Terminated

Location

Barbara Ann Karmanos Cancer Institute

Start Date

2007-08

Trial ID

NCT00020722

Treatments Being Tested

therapeutic autologous lymphocytes Ifosfamide, carboplatin, and etoposide (ICE) regimen Cyclophosphamide, Thiotepa, Carboplatin (CTC) or STAMP V (CTC)Leukapheresis peripheral blood stem cell transplantation (PBSCT)

Previous Next